Holen Sie sich die Stockscreener-App
3.40
9.32%
0.29
Handel nachbörslich:
3.31
-0.09
-2.65%
Schlusskurs vom Vortag:
$3.11
Offen:
$3.17
24-Stunden-Volumen:
42,538
Relative Volume:
0.59
Marktkapitalisierung:
$28.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.46M
KGV:
-0.2429
EPS:
-14
Netto-Cashflow:
$-24.56M
1W Leistung:
+4.62%
1M Leistung:
+16.84%
6M Leistung:
+16.44%
1J Leistung:
+75.26%
1-Tages-Spanne:
$3.03
$3.4207
1-Wochen-Bereich:
$2.965
$3.4207
52-Wochen-Spanne:
$1.20
$12.15
Evaxion A S Adr Stock (EVAX) Company Profile
Compare EVAX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
3.40 | 25.94M | 0 | -11.46M | -24.56M | -14.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Evaxion A S Adr Stock (EVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Maxim Group | Buy |
| 2024-04-02 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | Eingeleitet | H.C. Wainwright | Buy |
Evaxion A S Adr Aktie (EVAX) Neueste Nachrichten
Evaxion to announce business update and full year 2025 financial results on March 5, 2026 - GlobeNewswire Inc.
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN
European ADRs Edge Higher Despite Mixed Stock Moves - Finimize
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Target Price at $12.33 - Defense World
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Sahm
European Firms Make Gains On US Markets As ADR Index Rises - Finimize
Evaxion Biotech Reports Strong Q3 2025 Results - MSN
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Price Target at $12.33 - Defense World
European ADRs Edge Up With Gains Led By Evaxion - Finimize
Evaxion Biotech’s Earnings Call Highlights Strategic Growth - TipRanks
Analysts Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) PT at $12.33 - Defense World
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
European ADRs Barely Budge While Gainers And Losers Trade Places - Finimize
Evaxion A/S (NASDAQ:EVAX) Given Buy Rating at HC Wainwright - Defense World
European ADRs Edge Higher As Healthcare Leads Gains - Finimize
Take off with Evaxion A/S ADR (EVAX): Get ready for trading - setenews.com
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Sees Large Growth in Short Interest - Defense World
Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough - ts2.tech
Nothing is Better Than Connexa Sports Technologies Inc (YYAI) stock at the moment - Setenews
Biotech Stocks Lead European ADRs Higher On Wall Street - Finimize
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
Finanzdaten der Evaxion A S Adr-Aktie (EVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):